BEAM FY 2019 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

BEAMBeam Therapeutics Inc.

$3B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$18,000

Gross Profit

-$55M-303338.9% margin

Operating Income

-$75M-417522.2% margin

Net Income

-$78M-435144.4% margin

EPS (Diluted)

$-1.53

Cash Flow

Operating Cash Flow

-$72M

Free Cash Flow

-$85M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$156M

Total Liabilities

$55M

Stockholders' Equity

$101M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18,000	$0	—
Gross Profit	-$55M	-$34M	-61.2%
Operating Income	-$75M	-$46M	-64.3%
Net Income	-$78M	-$115M	+32.0%